Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
|
Jul 2023
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
|
Jul 2023
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria
|
Jul 2023
|
Clinical and Experimental Medicine
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress
|
Jul 2023
|
Expert Review of Anticancer Therapies
|
myelodysplastic syndromes (MDS)
|
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes
|
Jul 2023
|
European Journal of Haematology
|
myelodysplastic syndromes (MDS)
|
Considerations for Drug Development in Myelodysplastic Syndromes
|
Jul 2023
|
Clinical Cancer Research
|
myelodysplastic syndromes (MDS)
|
Long term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
|
Jul 2023
|
Haematologica
|
aplastic anemia
|
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia
|
Jul 2023
|
Annals of Hematology
|
aplastic anemia
|
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review
|
Jul 2023
|
Blood Reviews
|
myelodysplastic syndromes (MDS)
|
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review
|
Jul 2023
|
Experimental Hematology & Oncology
|
myelodysplastic syndromes (MDS)
|